Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human HGFR/c-MET Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB3581500
This item is not returnable.
View return policy
Description
HGFR/c-MET Monoclonal specifically detects HGFR/c-MET in Human samples. It is validated for Immunohistochemistry, Immunocytochemistry, ELISA Capture (Matched Antibody Pair).Specifications
HGFR/c-MET | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
AUTS9, c-Met, cMET, EC 2.7.10, EC 2.7.10.1, hepatocyte growth factor receptor, HGF R, HGF receptor, HGF/SF receptor, HGFR, MET, Met (c-Met), met proto-oncogene (hepatocyte growth factor receptor), met proto-oncogene tyrosine kinase, oncogene MET, Proto-oncogene c-Met, RCCP2, Scatter factor receptor, SF receptor, Tyrosine-protein kinase Met | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
4233 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
ELISA | |
85503 | |
ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
P08581 | |
MET | |
Mouse myeloma cell line NS0-derived recombinant human HGF R/c-MET Glu25-Thr932 Accession # P08581 | |
500 μg | |
Primary | |
Detects human HGF R/c-MET in ELISAs. In sandwich immunoassays, no cross-reactivity with recombinant human (rh) EGFR or rhIGF-1 R is observed. | |
Human | |
Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction